Aug 23 (Reuters) - Biotalys NV BTLS.BR :
* CASH AND CASH EQUIVALENTS AMOUNTED TO EUR 32 MILLION END
OF JUNE
2023
* SUCCESSFUL CFO SUCCESSION WITH DOUGLAS MINDER IN FUNCTION
SINCE
JULY 1ST
* PRIVATE PLACEMENT OF NEW SHARES FOR EUR 7 MILLION AT
MARKET
VALUE
* OTHER OPERATING INCOME FOR THE FIRST HALF OF 2023 AMOUNTED
TO
EUR 1.3 MILLION
* EXCLUDING FUNDS RAISED IN PRIVATE PLACEMENT OF JUNE 2023,
EXPECTS CASH BURN FOR FY TO BE SLIGHTLY LOWER THAN IN FY 2022
(2022: EUR 22 MILLION)
* BIOTALYS EXPECTS TO INITIATE THE MARKET CALIBRATION OF
EVOCA IN
2024 WITH BIOBEST IN SELECTED U.S. STATES UPON REGISTRATION OF
THE PRODUCT
Source text for Eikon: ID:nGNEHqzvx
Further company coverage: BTLS.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;))